The role of Tg kinetics in predicting 2-[18F]-FDG PET/CT results and overall survival in patients affected by differentiated thyroid carcinoma with detectable Tg and negative 131I-scan
Sign Up to like & getrecommendations! Published in 2021 at "Endocrine"
DOI: 10.1007/s12020-021-02755-5
Abstract: The aim of this study was to assess the potential role of thyroglobulin (Tg) kinetics in predicting 2-[18F]-FDG-PET/CT results and overall survival (OS) in patients affected by differentiated thyroid carcinoma (DTC) and suspected recurrence. On… read more here.
Keywords: negative 131i; fdg pet; predicting 18f; 18f fdg ... See more keywords
Amnestic MCI Patients’ Perspectives toward Disclosure of Amyloid PET Results in a Research Context
Sign Up to like & getrecommendations! Published in 2017 at "Neuroethics"
DOI: 10.1007/s12152-017-9313-z
Abstract: BackgroundResearchers currently are not obligated to share individual research results (IRR) with participants. This non-disclosure policy has been challenged on the basis of participants’ rights to be aware and in control of their personal medical… read more here.
Keywords: research; disclosure; brain amyloid; amyloid pet ... See more keywords
Interim FDG‐PET does not predict outcome in advanced‐stage Hodgkin lymphoma patients treated with BEACOPP
Sign Up to like & getrecommendations! Published in 2019 at "British Journal of Haematology"
DOI: 10.1111/bjh.15602
Abstract: A recent study by Borchmann et al (2018), published in Lancet, included 1945 patients with advanced-stage Hodgkin lymphoma whose therapy was adapted on the basis of interim fludeoxyglucose positron emission tomography (FDG-PET) results after 2… read more here.
Keywords: interim fdg; hodgkin lymphoma; fdg pet; fdg ... See more keywords